Vaxcyte, Inc. PCVX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s shares (diluted)?
- Vaxcyte, Inc. (PCVX) reported shares (diluted) of 139.5M in Q1 2026.
- How has Vaxcyte, Inc.'s shares (diluted) changed year-over-year?
- Vaxcyte, Inc.'s shares (diluted) increased by 2.8% year-over-year, from 135.7M to 139.5M.
- What is the long-term trend for Vaxcyte, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s shares (diluted) has grown at a 27.4% compound annual growth rate (CAGR), from 206.8M to 544M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.